Financhill
Sell
35

DGX Quote, Financials, Valuation and Earnings

Last price:
$176.00
Seasonality move :
-0.1%
Day range:
$175.13 - $176.26
52-week range:
$148.70 - $197.55
Dividend yield:
1.79%
P/E ratio:
20.64x
P/S ratio:
1.83x
P/B ratio:
2.70x
Volume:
296.5K
Avg. volume:
1.1M
1-year change:
14.67%
Market cap:
$19.6B
Revenue:
$9.9B
EPS (TTM):
$8.52

Earnings Data

Next earnings date for DGX
Jan 27
2026
Most recent earnings per share
$2.15
Missed by $0.35
(Oct 21/2025)
Consensus Estimate
$2.50
(Oct 21/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

DGX Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
01/27/2026 Q4 $2.8B -- -- $2.36 --
10/21/2025 Q3 $2.7B $2.8B $2.15 $2.50 -$0.35
07/22/2025 Q2 $2.7B $2.8B $2.49 $2.57 -$0.09
04/22/2025 Q1 $2.6B $2.7B $1.94 $2.15 -$0.21
01/30/2025 Q4 $2.6B $2.6B $1.95 $2.18 -$0.24
10/22/2024 Q3 $2.4B $2.5B $1.99 $2.26 -$0.27
07/23/2024 Q2 $2.4B $2.4B $2.04 $2.33 -$0.30
04/23/2024 Q1 $2.3B $2.4B $1.72 $1.86 -$0.14
02/01/2024 Q4 $2.3B $2.3B $1.70 $2.11 -$0.42
10/24/2023 Q3 -- $2.3B $1.96 -- --
07/26/2023 Q2 -- $2.3B $2.05 -- --
04/27/2023 Q1 -- $2.3B $1.78 -- --
02/02/2023 Q4 -- $2.3B $0.88 -- --
10/20/2022 Q3 -- $2.5B $2.15 -- --
07/21/2022 Q2 -- $2.5B $1.96 -- --
04/21/2022 Q1 -- $2.6B $2.93 -- --
02/03/2022 Q4 -- $2.7B $3.11 -- --
10/21/2021 Q3 -- $2.8B $4.02 -- --
07/22/2021 Q2 -- $2.6B $4.94 -- --
04/22/2021 Q1 -- $2.7B $3.47 -- --
02/04/2021 Q4 -- $3B $4.20 -- --
10/22/2020 Q3 -- $2.8B $4.13 -- --
07/23/2020 Q2 -- $1.8B $1.35 -- --
04/22/2020 Q1 -- $1.8B $0.73 -- --
01/30/2020 Q4 -- $1.9B $1.85 -- --
10/22/2019 Q3 -- $2B $1.56 -- --
07/23/2019 Q2 -- $2B $1.66 -- --
04/23/2019 Q1 -- $1.9B $1.20 -- --
02/14/2019 Q4 -- $1.8B $0.92 -- --
10/23/2018 Q3 -- $1.9B $1.53 -- --
07/24/2018 Q2 -- $1.9B $1.58 -- --
04/19/2018 Q1 -- $1.9B $1.27 -- --
02/01/2018 Q4 -- $1.9B $1.82 -- --
10/19/2017 Q3 -- $1.9B $1.14 -- --
07/25/2017 Q2 -- $1.9B $1.38 -- --
04/20/2017 Q1 -- $1.8B $1.16 -- --
01/26/2017 Q4 -- $1.9B $1.10 -- --
10/20/2016 Q3 -- $1.9B $1.34 -- --
07/21/2016 Q2 -- $1.9B $1.37 -- --
04/21/2016 Q1 -- $1.9B $0.72 -- --
01/28/2016 Q4 -- $1.8B $1.31 -- --

Quest Diagnostics, Inc. Earnings Questions

  • How Much did Quest Diagnostics, Inc. Generate in Revenue Last Quarter?

    Quest Diagnostics, Inc. reported $2.8B worth of top line sales in its most recent quarter.

  • Did Quest Diagnostics, Inc. Beat Earnings Last Quarter?

    Quest Diagnostics, Inc. announced earnings per share of $2.15 which represents a miss of analyst forecast a $2.50 per share.

  • Is Quest Diagnostics, Inc. Profitable?

    Quest Diagnostics, Inc. reported $911M that represents $8.06 per share over the last quarter.

  • What is the Analyst Consensus for Quest Diagnostics, Inc. EPS Next Year?

    Quest Diagnostics, Inc.'s earnings are forecast to grow from $7.66 per share to $8.90 per share next year representing an increase of 28.02%.

  • When is Quest Diagnostics, Inc.'s Earnings Date?

    Quest Diagnostics, Inc.'s next earnings date is January 27, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
57
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
64
GLTO alert for Dec 26

Galecto, Inc. [GLTO] is up 16.92% over the past day.

Buy
80
TVTX alert for Dec 26

Travere Therapeutics, Inc. [TVTX] is down 1.54% over the past day.

Sell
27
CDNAF alert for Dec 26

Canadian Tire Corp. Ltd. [CDNAF] is down 10% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock